Dr. Christina Rångemark Åkerman is President of ICHOM and Senior Institute Associate at the Institute for Strategy and Competitiveness (ISC) at Harvard Business School. Between 2008 and 2014, she served as Director General for the Medical Products Agency (MPA) in Sweden, a national agency employing approximately 750 people and under the aegis of the Swedish Ministry of Health and Social Affairs. During this period, she was also a Member of the Board of the European Medicines Agency (EMA), which is responsible for the scientific evaluation of medicines for use in the European Union. Before her position with MPA, Christina served as Vice President Medical of AstraZeneca Sweden as well as Marketing Company President of AstraZeneca Philippines. She has also been working chair of start-up companies and on the Board of Fouriertransform, a Swedish state-owned venture capital company. Christina received her medical degree from the University of Linköping. She wrote her doctoral thesis in Clinical Physiology and is a specialist in Clinical Pharmacology. She has an Executive MBA in General Management from the Stockholm School of Economics.

Prof. Ran Balicer, MD, PhD, MPH serves as Founding Director of the Clalit Research Institute, an award-winning data-driven health innovation center that was designated as the WHO Collaborating Center on Non-Communicable Diseases Research, Prevention and Control. In Parallel, he serves as Director of Health Policy Planning for Clalit - Israel's largest healthcare organization. In these roles, he is responsible for strategic planning of novel organization-wide interventions for improving healthcare quality, reducing disparities and increasing care effectiveness. These include the introduction of data-driven innovative tools into practice - predictive modeling, real-life effectiveness markers, decision support tools and proactive preventive care.   Prof Balicer also serves as a Full Professor and Track Director in the MPH program at the Ben-Gurion University, Israel. He has published over 170 peer-review publications, books, and book chapters. His research is focused on the study of extensive clinical databases in care provision and policymaking, integrated care, and quality management. Prof. Balicer serves as Chair of the Israeli Society for Quality in Healthcare, as immediate past president of ISPOR-Israel, and as an Advisor to Israeli Ministry of Health. He also serves as a Board Member of the International Foundation for Integrated Care, and as Council Member of the European Federation for Medical Informatics.   Prof. Balicer serves in senior advisory groups to the World Health Organization (WHO) Regional Office for Europe - including the Region’s Senators Group, and is involved in projects focusing on chronic diseases monitoring, prevention and control, and healthcare systems integration.  

Nicola studied business and human resource management in the UK and France. She was the founding Director of the European Disability Forum, an umbrella organisation uniting over 70 European disability NGOs to advocate for the human rights and inclusion of disabled citizens in Europe (1996 to 1999), and prior to this she worked as an external expert for the European Commission, heading the NGO unit within the HELIOS Programme (1991-1996). From 2004 to 2006, she worked for the Swiss Government, leading the Environment and Schools Initiatives Secretariat (ENSI), an international government-based network set up by OECD focussing on innovation, action research and policy development in the field of Education for Sustainable Development. Whilst in Switzerland, she has also worked as an independent consultant/evaluator, specialising in European social and development policy and health advocacy. Nicola joined the European Patients’ Forum as its first Executive Director in June 2006.

C’est en 1998 qu’Alain Michel CERETTI crée l’association Le LIEN, à la suite de l'affaire des contaminations par Mycobacterium xenopi, responsable d’une infection de la colonne vertébrale, à la clinique du Sport à Paris. Il en sera président jusqu’en 2006 avant de créer et présider la MIDISS, rattachée à la Haute Autorité de Santé. En 2009, Il fonde le pôle santé auprès du Médiateur de la République puis du Défenseur des Droits. Il co-préside les assises du médicament après le scandale du Médiator en 2011. Alain Michel CERETTI a consacré de nombreuses années à représenter les patients et, en tant que Président de France Assos Santé, il s’est engagé à « exprimer la voix des usagers du système de santé afin de constituer un contre-pouvoir défendant leurs intérêts ».                                                                                                                                                             Parcours professionnel ou activités (faits marquants):

• Président de France Assos Santé, Union Nationale des Associations Agréées du Système de Santé (depuis Juin 2017)
• Représentant des usagers au conseil d’administration de l’ANSM (2016)
• Conseiller droits des personnes malades du Défenseur des Droits (2012-2017)
• Co-Présidence (avec Edouard Couty) des assises du Médicament (2011)
• Fondateur du pôle santé du Médiateur de la République avec Jean-Paul Delevoye (2009)
• Président de la mission MIDISS (Mission nationale d’Information et de Dialogue pour la Sécurité des Soins) rattachée à la Haute Autorité de Santé (2006-2009)
• Fondateur et Président de l’association Le LIEN (Lutte Information Études des Infections Nosocomiales) (1997 – 2006)

 

Béatrice Cochener-Lamard is the Head of the Ophthalmology Department in Brest University Hospital (France) since 2000 and professor since 2002. She has been president of the French Society of Ophthalmology (SFO) for three years (2009-2011), is deputy president of the National Association of Ophthalmology (SNOF) and past- president of the French Society of Cataract and Refractive Surgery (SAFIR). Since 2011, she has been head of the French Academy of Ophthalmology, which is the national professional board of ophthalmology. She is involved in the international arena as ESCRS board member and President since 2018, social secretary of Eucornea and member of ICO educational committee. Her main fields of interest are anterior segment, refractive surgery and corneal surgery. In 2013, she was awarded the Legion of Honor, a French distinction of high merit. In terms of research activities, she is a member of the Medical Imaging Laboratory (Brest Inserm LATim). Invited to many conferences across the world, she has contributed to more than 200 publications and was in charge of the SFO national report dedicated to Presbyopia in 2012 and associated to the one on Ocular Surface in 2016 and 2 books on refractive surgery published in 2016.

  As Head of the OECD Health Division, Francesca Colombo (M.Sc) oversees OECD work on health, which aims at providing internationally comparable data on health and health systems, and at applying economic analysis to health policies, advising policy makers, stakeholders and citizens on how to respond to demands for more and better health.   Main activities of the Division she manages cover: health spending trends; measuring of health care outcomes, activities and inputs; health care quality policies; assessing of health system efficiency and value for money; long-term care systems and ageing; the economics of public health; pharmaceutical policies and new technologies; and health workforce. Major publications resulting from the work of the Division include Health at a Glance, Tackling Harmful Alcohol Use, Making Mental Health Count, Health Data Governance, and many others (http://www.oecd.org/health).   Mrs Colombo has over 20 years of experience leading international activities on health and health systems. She led among others projects on quality of health care policies, health financing and the impact of private health insurance on health systems, health workforce and the international migration of doctors and nurses. She has been responsible for OECD Asian Social and Health activities, working with the OECD/Korea Policy Centre.   Mrs Colombo is a leading international expert on health and care issues for elderly populations and also held responsibilities for co-ordinating OECD involvement at high-level meetings such as on diabetes, dementia and health workforce. Prior to joining OECD in 1999, she was seconded to the Ministry of Health and Labour of Guyana as Acting Head of the Planning Unit, where she was instrumental to the implementation of financing and governance reforms of the health system, and also worked at UNCTAD. Over her career, she has travelled extensively in Europe, South America and Asia, advising governments on health system policies and reforms.

Laurence Compte-Arassus is the President of Medtronic France since February 2015. She is a member of the board of the National Union of Medical Technologies (Syndicat National des Technologies Médicales – SNITEM). Starting her career with ESC (European Computer System) before joining Boston Scientific, she has spent most of her career in medical technology. She joined Medtronic in 2002 and held several managerial positions within the Cardiac Rhythm and Heart Failure (CRHF) Business Unit. In 2008, she was appointed Director of the Diabetes Group in France. In 2012 she became Director of the Cardiac and Vascular Group (CVG) in France. Laurence Compte-Arassus hold a Masters of ESTA in Belfort and is also graduated from Glasgow Caledonian University and the Wharton University of Pennsylvania. She has extensive management experience in sales and marketing.

Frédéric Dardel, graduated from the Polytechnic School and is a Doctor of cell and molecular biology. After being director of research at CNRS, he joined the University in 2000. He is currently professor at the Faculty of Pharmacy, where he heads the Laboratory of Crystallography and NMR and biological institute Descartes University / Diderot "Medicine, Toxicology, chemistry and Environment" that he created. He is involved in teaching molecular biology and biochemistry at all levels: ASPP, L2 and L3, Master, Doctoral School, and in the dual courses "Medicine / Science" and "Pharmasciences". Frédéric Dardel was Director of the Department of Life Sciences of CNRS, he is Chairman of the Scientific Council of INRA and represents France on the board of the European Molecular Biology Laboratory in Heidelberg.

Eric Hans has always been active in respectively professional boards. From this perspective already 10 years ago he became engaged in quality, improvement and transparancy in health care. He is GastroIntestinal Surgeon at the Deventer Hospital, a teaching hospital in the Netherlands and one of the founders and director of the Dutch Insitute for Clinical Auditing, an organization facilitating 23 clinical registries with a nationwide coverage, initiating significant improvements in Healthcare in the Netherlands over the years (www.clinicalaudit.nl). He also is a member of the World Economic Forum Committee for Value Baded HealthCare and the GS1 Healthcare Clinical Advisory Committee.

Gérard Friedlander, MD, PhD was born in 1952. He is currently Professor of Physiology at Paris Descartes University School of Medicine, Head of the Department of Physiology at Georges Pompidou hospital, and Team Leader of the lab “Cellular homeostasis and signaling in liver and kidney pathophysiology” at Institut Necker Enfants Malades, Paris, France. He focused his experimental and clinical research on renal physiology and pathophysiology, water and mineral metabolism, calcium and phosphate homeostasis, chronic kidney diseases, and on the links between ageing, metabolism and homeostasis. He is the author of more than 200 original publications, and of review articles and book chapters. He has been a member of several Editorial Boards including Kidney International and a Subject Editor of Nephrology Dialysis Transplantation. The links between clinical practice, clinical investigation, experimental and translational research and medical education both on dedicated sites and through networks is a field of his interest and expertise.

Jan Hazelzet, MD PhD, Erasmus MC, Rotterdam, the Netherlands has a long clinical experience as Pediatric Intensivist, and Associate-Professor in Pediatrics. He gradually moved to the field of information and quality, first in the position of chief medical information officer of Erasmus MC, later as professor in Health Care Quality & Outcome. He is the clinical lead of the Value-Based Health Care Program in Erasmus MC and the shift towards a more Patient-Centered Care.

Professor at Karolinska Institute since 1998, firstly of Neurophysiology and of Integrative Medicine since 2007, Dr. Martin Ingvar has been leading research activities at the Osher Center for Integrative Medicine and became Dean of Researchbetween 2010 and 2013. He has been Deputy Vice-Chancellor for Future Healthcare and then Deputy Vice-Chancellor for Development from 2014 to 2017. In 2012, he became a board member of the International Consortium for Health Measures alongside Michael Porter and Stefan Larsson.

Présidente Fondatrice du CNAO - Membre expert de la HAS (Haute Autorité de Santé) - Membre du CNA Interministériel (Ministère de l’économie, de la santé, de l’alimentation, de l’écologie) Anne Sophie Joly est experte en communication santé grand public. Elle est Présidente Fondatrice du CNAO (Collectif National des Associations d'Obèses). Elle est également: - Membre expert de la HAS (Haute Autorité de Santé) - Membre du CNA (Conseil National de l'Alimentation Interministériel).

Gregory Katz is Chaired Professor of Innovation Management & Healthcare Performance at the University Paris-Descartes Medical School. He is also Director of Research & Innovation at ELSAN, a leading group of private hospitals with 2 million patients treated each year by 6,500 practioners in 120 clinics across France. His publications focus on industrial economics and health policy applied to medical genomics & stem cell banking. His most recent research is dedicated to value-based healthcare, the development of PROM instruments, and their impact on medical team behavior and culture. In 2009, he received the San Benedetto International Award for his achievements in bioethics and humanism. In 2015, he was invited as an eminent scholar for the Grand Rounds Lecture at the UCLA Fielding School of Public Health. Since 2018, he chairs the scientific board of Digital Leaders in Health, a think tank dedicated to connected health.

Thomas Kelley leads ICHOM’s administration across its London and Boston offices. He also has global responsibility for ICHOM’s partnerships and for the day-to-day management of the London office. Prior to working at ICHOM he practiced as a physician at an Academic Medical Centre in the UK, Oxford University Hospitals (OUH). Whilst at the OUH he worked in many parts of the hospital including general adult medicine, trauma and orthopedics, general surgery, emergency medicine, and plastic surgery. He received his BSc and MD from the University of Manchester and MBA from the University of Oxford.

Morten Kildal is a consultant in Plastic Surgery and Burn Care and he is since 2013 the lead manager of the implementation and follow up of Value Based Health Care at Uppsala University Hospital. He was previously head of the Department of Plastic and Maxillofacial Surgery for six years engaged in change management and the implementation of Lean Health Care with a special focus on quality improvements and patient participation in a team based setting. He has also been engaged in the development of a structured and clinically focused quality management system that is currently certified according to international standards of ISO 9001 and SS-EN 15224. One of his main research focuses has been the development and use of PREMs (Patient Reported Experience Measures) and PROMs (Patient Reported Objective Measures) for burn patients as wells as research connected to different aspects of outcomes after reconstructive plastic surgery. He has participated in several international workgroups on different aspects of identifying patient relevant outcome measures and utilizing these data in daily improvement work. His clinical work is focused on Burn Care in the National Burn Unit in Uppsala.

David Lansky, PhD, is the president and Chief Executive Officer of the Pacific Business Group on Health (PBGH) and Senior Advisor to the International Consortium for Health Outcomes Measurement (ICHOM). At PBGH, he directs the efforts of employers and public agencies representing 12 million Americans to obtain high-value health care. PBGH works closely with ICHOM to encourage adoption of standard outcome measure sets across US health care. He also represents purchaser perspectives on several US policy bodies advising Congress and Administration agencies and is Chair of the Health Care Transformation Task Force comprised of large health care systems, payors, and patient advocates.

Corinne M. Le Goff joined Amgen in 2015 as senior vice president, Regional General Manager. Le Goff is head of Amgen's European Region. Before joining Amgen, Le Goff was president of Roche's French affiliate. Prior to her role in France, she spent five years in strategic commercial leadership roles managing large therapeutic areas at both Roch, where she was senior vice president of Global Product Strategy for the Neurosciences franchise, and at Merck Serono, where she was senior vice president of Strategy and Global Marketing for Neurology, Rheumatology, and Immunology. Prior to Merck Serono, Le Goff was senior vice president of U.S. Commercial Operations Empowered Regions at Sanofi-Aventis. Le Goff received a Pharm. D. from the University Paris V and an MBA in Marketing from La Sorbonne University, France.

PHD in Biophysics, Dominique Le Guludec is Professor of Biophysics and Nuclear Medicine at University Paris 7. Head of the department of nuclear medicine from 1993 to 2017, which has the most important activity in Nuclear Medicine in Paris, based on functional and molecular imaging in the field of cardiovascular diseases among others. Prof. Le Guludec has an international expertise in molecular imaging and authored more than 165 articles in high ranking journals. She was the head of the Inserm Research Group “Cardiovascular Imaging” within the Bichat INSERM U1148 – Laboratory for Vascular Translational Science (LVTS) and of the pre-clinical multi-modality imaging platform UMS 34. She was the director of the board of IRSN from 2013 to 2017, and director of the medical board of the hospital group HUPNVS-APHP-Paris. She has been appointed Chairwoman of the French National Authority for Health (HAS – Haute Autorité de santé) on December 2017.  

Teus Linsen, MD, PhD, is currently account manager strategic partners at health insurer Menzis. He is involved in the development of innovative value based healthcare contracts in Netherlands. Together with strategic partners Menzis aims for higher value of care at three different levels. For the whole population, within the individual healthcare institutions (mainly hospitals) and at the level of different medical conditions, through VBHC contracts using bundled payments.

• since 11/2012 CEO, Martini-Klinik am UKE GmbH • since 01/2011 Managing Director, Institut für Pathologie, Universitätsklinikum Hamburg-Eppendorf (UKE) • 2006 - 2010 Head of Marketing Department, LADR Medical Laboratories and ISG Intermed Service GmbH & Co. KG, Geesthacht • 2002 - 2005 Marketing Assistant, ISG Intermed Service GmbH & Co. KG • 1997 - 2002 PhD Thesis under kind guidance of Prof. Dr. med. G. Gercken, Universität Hamburg, Institut für Biochemie und Lebensmittelchemie, Abteilung für Biochemie und Molekular-biologie. The practical work was in the research laboratory of Krankenhaus Großhansdorf, Zentrum für Pneumologie und Thoraxchirurgie, Großhansdorf and in the medical laboratory Dr. Kramer and colleagues in Geesthacht.

Jérôme NOUZAREDE, 47, graduated from Ecole Polytechnique et des Ponts & Chaussées. He holds a postgraduate degree in Management from the University Paris Dauphine. He founded VEDICI, a private hospital group, in 2000, with Dr. Michel BODKIER. The group became ELSAN in 2016. He is now Chairman of The Board of Directors.

Professor Patrick Pessaux is the Head of the Hepato-Biliary and Pancreatic surgical Unit in the Department of Digestive and Endocrine Surgery at the University Hospital of Strasbourg. Highly interested in new technologies, he develops an innovative minimally invasive hepatobiliary and pancreatic surgery, using new technologies including robotics and image-guided surgery at the Hospitalo-University Institute (IHU) of Strasbourg where he is Deputy Medical Director. He is very interested in the functioning and the mechanisms of our health system. He holds a PhD degree in "Methods and Analyzes of Health Systems" in Lyon 1. Convinced of the need for a transformation of our health system, making a greater part in the evaluation of quality, he becomes a member of the "Cercle Valeur Santé" and initiates the coordination of a research project, within the Strasbourg IHU of innovation, organizational centered on the optimization of the patient's health pathway with its evaluation qualitative. He is member of the fundamental research unit INSERM U1110 LabEx HepSys « Interactions virus-hôtes et maladies hépatiques ». For humanitarian reasons, he co-founded, in 2009, the medical association Ulysse "recognized as public utility" medical aid in Peru to identify and treat some of the most disadvantaged people in Peru, without social security.

Michael Eugene Porter is an American academic known for his theories on economics, business strategy, and social causes. He is the Bishop William Lawrence University Professor at Harvard Business School, and he was one of the founders of the consulting firm The Monitor Group (now part of Deloitte) and FSG, a social impact consultancy. He is also one of the founder and member of the board of The International Consortium for Health Outcomes Measures (ICHOM)

Graduate from Sciences Po Paris in 1988 and ENA in 1993 Chief Counsellor at the "Cour des Comptes" (Court of Auditors) in 2010. Since 2014: General Director of the National Fund of Health Insurance for Salaried Employees and the National Union of Health Insurance Funds 2012 - 2014: Deputy General Secretary for the Presidency of the Republic in charge of public policies 2008 - 2012: Chief of Staff of the Mayor of Paris 2003 - 2008: Deputy Chief of Staff of the Mayor of Paris 2002 - 2003: returned to the Court of Auditors as public auditor 2000 - 2002: Technical Adviser to the Minister of Agriculture and Fisheries 1997 - 2000: seconded to the Ministry of Interior - General Secretary of the Prefecture of the Hautes-Pyrénées 1996: Public auditor of the Court of Auditors - 5th bedroom 1993: Auditor at the Court of Auditors - 5th bedroom

Helen Rochford-Brennan is the current Chairperson of the European Working Group of People with Dementia and is the group’s nominee to the Board of Alzheimer Europe; she is former Chair of the Irish Dementia Working Group. Helen is on the Monitoring Committee of Ireland’s first National Dementia Strategy. Throughout her time with these organisation she has campaigned to raise awareness of dementia, speaking at international conference’s, engaging with pharma, scientists, clinicians, educators, students and many research projects from developing evidence –based diagnosis to palliative care. Helen was diagnosed after a five year struggle with Early Onset Alzheimer’s at the age of 62 and has since written very personally about living with dementia.

Dr. Veronique L. Roger, M.D., M.P.H. has been Professor of Medicine and Epidemiology at College of Medicine, Mayo Clinic since 2007. Dr. Roger is a cardiologist, epidemiologist and outcomes researcher. Dr. Roger serves as Medical Director of Center for The Science of Health Care Delivery of Mayo Clinic Health System New Prague. She served as a Consultant of Division of Cardiovascular Diseases, Department of Medicine at Mayo Clinic, Rochester, Minn. From 2006 to 2009, she served as Chairman of Department of Health Sciences Research from 2006 to 2009. She has been a Director of CaringBridge Inc. since September 5, 2017. She has been a Trustee of Mayo Clinic since 2011 and serves as its Member of Board of Governors. She serves as Internal Trustee of Mayo Clinic Health System New Prague. Her research focuses on the occurrence and outcomes of cardiovascular diseases. She studied at University of Paris, Mayo School of Graduate Medical Education in Cardiology; Assistance Publique-Hopitaux de Paris; University of Minnesota, School of Public Health. Dr. Roger is a Diplomate from American Board of Internal Medicine (Internal Medicine/Cardiovascular Disease).

Zirui Song, M.D., Ph.D. is an Assistant Professor of Health Care Policy at Harvard Medical School and an internal medicine physician at Massachusetts General Hospital. His research focuses on changes in health care spending and quality under global payment, the impact of Medicare fee policies on spending and physician behavior, and the economics of competitive bidding in Medicare Advantage. Dr. Song has worked in the U.S. Department of Health and Human Services and served as a Visiting Fellow at the Health Policy Commission in Massachusetts. He received his M.D. from Harvard Medical School magna cum laude and his Ph.D. in Health Policy (Economics) from Harvard University, where he was a fellow in Aging and Health Economics at the National Bureau of Economic Research. He completed his residency training at Massachusetts General Hospital.

Olivier VERAN, Member of the French Parliament, General Rapporteur of the Committee on Social Affairs in the National Assembly where he is, every year, in charge of the project on the Social Security Financing Bill. He is also a Neurologist, Hospital practitoner in Grenoble University Hospital Center. He gratuated from Sciences Po Paris in 2013, in Health Politics & Management. He was the French President Macron’s Special Adviser on Smart Healthcare issues during his election campaign.

Didier spent most of his career within AXA where he held both senior technical and commercial management roles before becoming CEO of the Employee Benefits business in France. He joined AXA France Executive Committee in 2011. Since October 2013, Didier is now President of the ARRCO Board of Directors and a member of the MEDEF Social Protection Committee.Didier graduated from ENSAM and IAE. He is a fellow of the French Institute of Actuaries.